FCRL1 immunoregulation in B cell development and malignancy.
B cell receptor
B cells
FCRL1
immunotherapy
lymphocyte development
malignancy
signaling
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
30
06
2023
accepted:
01
09
2023
medline:
2
11
2023
pubmed:
12
10
2023
entrez:
12
10
2023
Statut:
epublish
Résumé
Immunotherapeutic targeting of surface regulatory proteins and pharmacologic inhibition of critical signaling pathways has dramatically shifted our approach to the care of individuals with B cell malignancies. This evolution in therapy reflects the central role of the B cell receptor (BCR) signaling complex and its co-receptors in the pathogenesis of B lineage leukemias and lymphomas. Members of the Fc receptor-like gene family (
Identifiants
pubmed: 37822931
doi: 10.3389/fimmu.2023.1251127
pmc: PMC10562807
doi:
Substances chimiques
Receptors, Fc
0
Receptors, Cell Surface
0
FCRL1 protein, human
0
Membrane Proteins
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1251127Informations de copyright
Copyright © 2023 Mamidi, Huang, Honjo, Li, Tabengwa, Neeli, Randall, Ponnuchetty, Radic, Leu and Davis.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Mol Cell. 2002 Nov;10(5):1057-69
pubmed: 12453414
Nat Immunol. 2019 Aug;20(8):963-969
pubmed: 31285625
Mol Immunol. 2004 Jul;41(6-7):599-613
pubmed: 15219998
Cancer Discov. 2015 Dec;5(12):1282-95
pubmed: 26516065
Nat Med. 2018 May;24(5):679-690
pubmed: 29713087
J Immunol. 2021 Dec 1;207(11):2688-2698
pubmed: 34697226
J Clin Oncol. 2019 Jan 20;37(3):202-212
pubmed: 30523719
EMBO J. 1984 Jun;3(6):1209-19
pubmed: 6086308
J Exp Med. 2020 Oct 5;217(10):
pubmed: 32603407
J Immunol. 2012 May 15;188(10):4741-5
pubmed: 22491254
Nat Rev Immunol. 2002 May;2(5):323-35
pubmed: 12033738
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Sci Signal. 2015 Sep 15;8(394):ra93
pubmed: 26373673
Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):E1282-90
pubmed: 23509253
Cancer Cell. 2013 Jun 10;23(6):826-38
pubmed: 23764004
Front Immunol. 2020 Oct 14;11:575175
pubmed: 33162991
Oncogene. 2004 Oct 18;23(48):8001-6
pubmed: 15489917
Blood Cancer J. 2019 Feb 4;9(2):17
pubmed: 30718503
Blood Adv. 2021 Jan 26;5(2):602-606
pubmed: 33496756
Annu Rev Immunol. 2007;25:525-60
pubmed: 17201682
Blood. 1999 Sep 15;94(6):1840-7
pubmed: 10477712
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7):
pubmed: 33563755
Blood. 2022 Nov 24;140(21):2193-2227
pubmed: 36001803
Nat Rev Clin Oncol. 2014 Jan;11(1):12-23
pubmed: 24217204
Nature. 2000 Feb 3;403(6769):503-11
pubmed: 10676951
Blood Adv. 2021 Jan 26;5(2):607-612
pubmed: 33496755
Annu Rev Immunol. 1997;15:453-79
pubmed: 9143696
N Engl J Med. 2001 Jul 26;345(4):241-7
pubmed: 11474661
Cell. 2009 Oct 30;139(3):573-86
pubmed: 19879843
N Engl J Med. 2018 Apr 12;378(15):1396-1407
pubmed: 29641966
Immunity. 2001 Sep;15(3):363-74
pubmed: 11567627
J Immunol. 2010 Jul 1;185(1):23-7
pubmed: 20519654
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12420-5
pubmed: 23840064
Cancer Res. 2023 Apr 14;83(8):1214-1233
pubmed: 36779841
Nat Rev Immunol. 2008 Jan;8(1):34-47
pubmed: 18064051
Blood. 2002 Apr 15;99(8):2662-9
pubmed: 11929751
Cancer Cell. 2020 Apr 13;37(4):551-568.e14
pubmed: 32289277
Nature. 2001 Jul 19;412(6844):341-6
pubmed: 11460166
Leuk Res Rep. 2019 Aug 14;12:100181
pubmed: 31467839
Immunity. 1999 Nov;11(5):547-54
pubmed: 10591180
J Immunol. 2004 Mar 1;172(5):2731-8
pubmed: 14978070
Elife. 2014 Jun 24;3:e02069
pubmed: 24963139
Haematologica. 2011 Jul;96(7):996-1001
pubmed: 21546504
J Immunol. 2013 Jun 1;190(11):5739-46
pubmed: 23616577
Cell. 1997 Sep 19;90(6):1073-83
pubmed: 9323135
Cell. 2004 Jun 11;117(6):787-800
pubmed: 15186779
Nat Rev Cancer. 2005 Apr;5(4):251-62
pubmed: 15803153
Immunogenetics. 2002 May;54(2):87-95
pubmed: 12037601
Immunol Rev. 2012 May;247(1):52-63
pubmed: 22500831
Curr Top Microbiol Immunol. 2014;382:29-50
pubmed: 25116094
Leukemia. 2012 Sep;26(9):2103-13
pubmed: 22437443
Cancer Cell. 2017 Mar 13;31(3):383-395
pubmed: 28262555
Nat Rev Drug Discov. 2013 Mar;12(3):229-43
pubmed: 23449308
Int J Mol Sci. 2023 Feb 25;24(5):
pubmed: 36901962
J Immunol. 2010 Dec 15;185(12):7405-12
pubmed: 21068405
Eur J Immunol. 2013 Nov;43(11):2980-92
pubmed: 23857366
Blood. 2008 Jun 15;111(12):5446-56
pubmed: 18216293
Nat Rev Immunol. 2006 Apr;6(4):283-94
pubmed: 16557260
Nat Genet. 2011 Jul 31;43(9):830-7
pubmed: 21804550
Nat Rev Clin Oncol. 2020 Jul;17(7):418-434
pubmed: 32242094
Nature. 2012 Oct 4;490(7418):116-20
pubmed: 22885699
Science. 2007 Apr 13;316(5822):291-4
pubmed: 17431183
Cancer Cell. 2003 Feb;3(2):185-97
pubmed: 12620412
Front Immunol. 2017 Oct 04;8:1245
pubmed: 29046676
Annu Rev Immunol. 2000;18:393-422
pubmed: 10837064
Front Immunol. 2022 Jan 12;12:825813
pubmed: 35095929
Immunol Rev. 2019 Sep;291(1):190-213
pubmed: 31402495
N Engl J Med. 2022 Jan 27;386(4):351-363
pubmed: 34904799
Nat Immunol. 2003 Mar;4(3):274-9
pubmed: 12563261
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):226-232
pubmed: 31808880
Front Oncol. 2018 Jun 04;8:163
pubmed: 29915719
Immunol Res. 1998;17(1-2):3-11
pubmed: 9479562
Immunity. 2021 Aug 10;54(8):1652-1664
pubmed: 34380063
Nat Med. 2019 Sep;25(9):1341-1355
pubmed: 31501612
Nature. 1995 Jul 27;376(6538):352-5
pubmed: 7543183
N Engl J Med. 2006 Jun 8;354(23):2431-42
pubmed: 16760443
Eur J Immunol. 2008 Nov;38(11):3159-66
pubmed: 18991291
Nat Immunol. 2011 Sep 20;12(10):933-40
pubmed: 21934679
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9772-7
pubmed: 11493702
Blood Cancer J. 2019 May 15;9(6):47
pubmed: 31092813
J Biol Chem. 2004 Dec 10;279(50):51931-8
pubmed: 15456754
Cell. 2019 Apr 18;177(3):524-540
pubmed: 31002794
Blood. 2008 Sep 1;112(5):1923-30
pubmed: 18577710
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2463-8
pubmed: 9482908
Nat Med. 2021 Aug;27(8):1419-1431
pubmed: 34312556
Immunity. 2016 Sep 20;45(3):471-482
pubmed: 27653600
Lancet Oncol. 2020 Jul;21(7):978-988
pubmed: 32511983
Sci Rep. 2018 Mar 9;8(1):4244
pubmed: 29523808
Immunol Rev. 2004 Feb;197:179-91
pubmed: 14962195
Cell Rep. 2020 Feb 4;30(5):1292-1299.e3
pubmed: 32023449
Nat Chem Biol. 2005 Jul;1(2):93-7
pubmed: 16408005
Proc Natl Acad Sci U S A. 1976 Oct;73(10):3628-32
pubmed: 824647
Nature. 2010 Jan 7;463(7277):88-92
pubmed: 20054396
Annu Rev Immunol. 2002;20:165-96
pubmed: 11861601
Int Immunol. 2004 Sep;16(9):1343-53
pubmed: 15302849
Nature. 1989 Mar 30;338(6214):383-4
pubmed: 2927501
Mol Biol Rep. 2023 Feb;50(2):1133-1145
pubmed: 36409389
Br J Haematol. 2015 Dec;171(5):763-75
pubmed: 26471982
Nat Rev Immunol. 2003 Apr;3(4):317-30
pubmed: 12669022
Haematologica. 2018 May;103(5):e215-e218
pubmed: 29419431
Immunol Lett. 2011 Jan 30;134(2):113-21
pubmed: 20951740
Int Immunol. 2006 Sep;18(9):1363-73
pubmed: 16849395
Blood. 2008 Jul 1;112(1):179-87
pubmed: 18314442
Blood. 2005 Feb 1;105(3):1121-6
pubmed: 15479727
J Exp Med. 1994 May 1;179(5):1725-9
pubmed: 7513017
Cancer Immunol Immunother. 2009 Jun;58(6):989-96
pubmed: 18802695
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13489-94
pubmed: 14597715
Cell. 2007 Jun 29;129(7):1261-74
pubmed: 17604717
Nat Rev Immunol. 2009 Nov;9(11):767-77
pubmed: 19855403
J Immunol. 2015 Jun 15;194(12):5851-60
pubmed: 25972488
Immunogenetics. 2007 Jun;59(6):493-506
pubmed: 17356879
Immunol Rev. 2002 Dec;190:123-36
pubmed: 12493010
Nature. 1991 Dec 5;354(6352):389-92
pubmed: 1956400
J Cancer Res Clin Oncol. 2022 Jan;148(1):177-190
pubmed: 34741682
Annu Rev Immunol. 2001;19:595-621
pubmed: 11244048
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9770-5
pubmed: 17522256
Clin Cancer Res. 2004 Aug 15;10(16):5327-34
pubmed: 15328168
Nat Rev Immunol. 2005 Mar;5(3):201-14
pubmed: 15719024
Nat Rev Immunol. 2015 Mar;15(3):191-7
pubmed: 25656707
Blood. 2007 May 1;109(9):3786-93
pubmed: 17213291
Blood. 2017 Aug 24;130(8):995-1006
pubmed: 28646116
Cancer Cell. 2021 Oct 11;39(10):1422-1437.e10
pubmed: 34597589
Best Pract Res Clin Haematol. 2011 Jun;24(2):203-16
pubmed: 21658619
Biomark Insights. 2019 Nov 19;14:1177271919882351
pubmed: 31798301
Blood. 2011 Dec 8;118(24):6332-41
pubmed: 21908428
Curr Opin Immunol. 2010 Jun;22(3):299-307
pubmed: 20434893
Int J Cancer. 2008 Nov 1;123(9):2113-9
pubmed: 18704934
J Immunol. 1996 Jan 15;156(2):866-72
pubmed: 8543844
Leukemia. 2022 Jan;36(1):189-196
pubmed: 34272481
Sci Immunol. 2016 Jul 14;1(1):
pubmed: 28217764
J Immunol. 2009 Nov 1;183(9):5502-10
pubmed: 19843936
Cancers (Basel). 2020 May 22;12(5):
pubmed: 32455989
Sci Adv. 2019 Jul 17;5(7):eaaw0315
pubmed: 31328160
Blood. 2008 Jan 1;111(1):338-43
pubmed: 17895404
Nat Immunol. 2008 Jan;9(1):63-72
pubmed: 18059271
Nat Rev Immunol. 2002 May;2(5):354-63
pubmed: 12033741
N Engl J Med. 2014 Jun 12;370(24):2286-94
pubmed: 24869598
Nature. 2023 Feb;614(7949):635-648
pubmed: 36813894
Annu Rev Immunol. 2012;30:565-610
pubmed: 22224767
J Immunol. 2020 Jul 15;205(2):533-538
pubmed: 32513851
Mol Ther Oncolytics. 2018 Nov 06;11:127-137
pubmed: 30581986
MAbs. 2019 Feb/Mar;11(2):422-433
pubmed: 30550367